TY - JOUR
T1 - Influence of African American race on the association between preoperative biopsy grade group and adverse histopathologic features of radical prostatectomy
AU - Aminsharifi, Alireza
AU - Schulman, Ariel
AU - Howard, Lauren E.
AU - Tay, Kae Jack
AU - Amling, Christopher L.
AU - Aronson, William J.
AU - Cooperberg, Matthew R.
AU - Kane, Christopher J.
AU - Terris, Martha K.
AU - Freedland, Stephen J.
AU - Polascik, Thomas J.
N1 - Publisher Copyright:
© 2019 American Cancer Society
PY - 2019/9
Y1 - 2019/9
N2 - Background: The current study was performed to evaluate the influence of race on the association between biopsy grade group (GrGp) and the risk of detectable prostate-specific antigen (PSA) and adverse histopathological outcomes after radical prostatectomy (RP). Methods: Data regarding 4073 men (1344 African American men; 33%) who were treated with RP were categorized based on the 5-tiered GrGp system. Logistic regression was used to test the association between biopsy GrGp and PSA nadir (<0.1 ng/mL) after RP as well as adverse pathological features among all patients and stratified by race. Results: Those patients with a higher biopsy GrGp were found to have lower odds of achieving a PSA nadir <0.1 ng/mL after RP on unadjusted and multivariable analysis (both P <.001). On unadjusted and multivariable analysis, higher GrGp was associated with increased odds of each of the adverse pathological features, namely, GrGp ≥3, extraprostatic extension, seminal vesicle invasion, positive surgical resection margin, and positive lymph nodes (all P <.001). Race had no significant interaction with biopsy GrGp in the prediction of PSA nadir after RP (P =.91) or any adverse pathological features (all P >.06) except positive lymph nodes. When the models were stratified by race, the associations between preoperative biopsy GrGp and having a PSA nadir <0.1 ng/mL, high-grade final pathology, or other adverse histopathologic features were similar in both races except as noted for positive lymph nodes. Conclusions: Higher preoperative biopsy GrGp is associated with increased odds of adverse histopathological findings as well as lower odds of a PSA nadir <0.1 ng/mL after RP. These associations are largely independent of race, suggesting that GrGp is an accurate tool for risk stratification in both black and white men.
AB - Background: The current study was performed to evaluate the influence of race on the association between biopsy grade group (GrGp) and the risk of detectable prostate-specific antigen (PSA) and adverse histopathological outcomes after radical prostatectomy (RP). Methods: Data regarding 4073 men (1344 African American men; 33%) who were treated with RP were categorized based on the 5-tiered GrGp system. Logistic regression was used to test the association between biopsy GrGp and PSA nadir (<0.1 ng/mL) after RP as well as adverse pathological features among all patients and stratified by race. Results: Those patients with a higher biopsy GrGp were found to have lower odds of achieving a PSA nadir <0.1 ng/mL after RP on unadjusted and multivariable analysis (both P <.001). On unadjusted and multivariable analysis, higher GrGp was associated with increased odds of each of the adverse pathological features, namely, GrGp ≥3, extraprostatic extension, seminal vesicle invasion, positive surgical resection margin, and positive lymph nodes (all P <.001). Race had no significant interaction with biopsy GrGp in the prediction of PSA nadir after RP (P =.91) or any adverse pathological features (all P >.06) except positive lymph nodes. When the models were stratified by race, the associations between preoperative biopsy GrGp and having a PSA nadir <0.1 ng/mL, high-grade final pathology, or other adverse histopathologic features were similar in both races except as noted for positive lymph nodes. Conclusions: Higher preoperative biopsy GrGp is associated with increased odds of adverse histopathological findings as well as lower odds of a PSA nadir <0.1 ng/mL after RP. These associations are largely independent of race, suggesting that GrGp is an accurate tool for risk stratification in both black and white men.
UR - http://www.scopus.com/inward/record.url?scp=85065233916&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85065233916&partnerID=8YFLogxK
U2 - 10.1002/cncr.32168
DO - 10.1002/cncr.32168
M3 - Article
C2 - 31042315
AN - SCOPUS:85065233916
SN - 0008-543X
VL - 125
SP - 3025
EP - 3032
JO - Cancer
JF - Cancer
IS - 17
ER -